Administration of low-dose resveratrol attenuated hepatic inflammation and lipid accumulation in high cholesterol-fructose diet-induced rat model of nonalcoholic fatty liver disease

Administration of low-dose resveratrol attenuated hepatic inflammation and lipid accumulation in high cholesterol-fructose diet-induced rat model of nonalcoholic fatty liver disease

Resveratrol (RSV) has been demonstrated to ameliorate nonalcoholic fatty liver disease (NAFLD) in animal studies. However, RSV was given with the dosage that ranged from 7 to 300 mg/kg body weight (BW). Hence, the study aimed to investigate the efficacy of RSV at a lower dosage on high cholesterol-f...

Full description

Bibliographic Details
Main Authors: Chih-Chun Chang, Chieh-Yu Chang, Pei-Chun Lin, Jiung-Pang Huang, Kuan-Hsing Chen, Tzung-Hai Yen, Li-Man Hung
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2020-01-01
Series:Chinese Journal of Physiology
Subjects:
high cholesterol-fructose diet
inflammation
interleukin
nonalcoholic fatty liver disease
resveratrol
stat3
Online Access:http://www.cjphysiology.org/article.asp?issn=0304-4920;year=2020;volume=63;issue=4;spage=149;epage=155;aulast=Chang

Similar Items

Similar Items